类风湿关节炎和银屑病关节炎患者在接受联合使用改善病情抗风湿药物治疗时的阿达木单抗谷浓度。 - Suppr

Adalimumab trough concentrations in patients with rheumatoid arthritis and psoriatic arthritis treated with concomitant disease-modifying antirheumatic drugs.

作者信息

Vogelzang E H, Pouw M F, Nurmohamed M, Kneepkens E L, Rispens T, Wolbink G J, Krieckaert C L M

机构信息

Department of Rheumatology, Jan van Breemen Research Institute | Reade, Amsterdam, The Netherlands.

Department of Rheumatology, Jan van Breemen Research Institute | Reade, Amsterdam, The Netherlands Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Centre, Amsterdam, The Netherlands.

出版信息

Ann Rheum Dis. 2015 Feb;74(2):474-5. doi: 10.1136/annrheumdis-2014-206588. Epub 2014 Nov 28.

DOI:10.1136/annrheumdis-2014-206588

PMID:25433018

Abstract

摘要

相似文献

Adalimumab trough concentrations in patients with rheumatoid arthritis and psoriatic arthritis treated with concomitant disease-modifying antirheumatic drugs.

Ann Rheum Dis. 2015 Feb;74(2):474-5. doi: 10.1136/annrheumdis-2014-206588. Epub 2014 Nov 28.

Towards an individualised target concentration of adalimumab in rheumatoid arthritis.

Ann Rheum Dis. 2014 Jul;73(7):1428-9. doi: 10.1136/annrheumdis-2013-204971. Epub 2014 Feb 18.

[Experience of monitoring subcutaneous biological treatment (adalimumab) by nurses in chronic inflammatory diseases].

Reumatol Clin. 2011 Sep-Oct;7(5):349-50. doi: 10.1016/j.reuma.2011.04.004. Epub 2011 Jun 30.

Anti-adalimumab antibodies and adalimumab concentrations in psoriatic arthritis; an association with disease activity at 28 and 52 weeks of follow-up.

Ann Rheum Dis. 2014 Dec;73(12):2178-82. doi: 10.1136/annrheumdis-2014-205554. Epub 2014 Aug 12.

Relationship between the clinical response to adalimumab treatment and serum levels of adalimumab and anti-adalimumab antibodies in patients with psoriatic arthritis.

Ann Rheum Dis. 2010 Mar;69(3):624-5. doi: 10.1136/ard.2009.108787.

Clinical relevance of monitoring serum levels of adalimumab in patients with rheumatoid arthritis in daily practice.

Clin Exp Rheumatol. 2014 Nov-Dec;32(6):942-8. Epub 2014 Oct 20.

Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).

J Rheumatol. 2003 Dec;30(12):2563-71.

[New drugs and treatment strategies for rheumatoid arthritis].

Recenti Prog Med. 2003 Sep;94(9):361-79.

Calprotectin and TNF trough serum levels identify power Doppler ultrasound synovitis in rheumatoid arthritis and psoriatic arthritis patients in remission or with low disease activity.

Arthritis Res Ther. 2016 Jul 8;18(1):160. doi: 10.1186/s13075-016-1032-z.

FDA OKs two new uses for biologic arthritis drug adalimumab.

Health News. 2006 Jan;12(1):2.

引用本文的文献

Duvelisib is a novel NFAT inhibitor that mitigates adalimumab-induced immunogenicity.

Front Pharmacol. 2025 Jan 9;15:1397995. doi: 10.3389/fphar.2024.1397995. eCollection 2024.

An Overview of Adalimumab Therapy for Ankylosing Spondylitis.

Curr Rheumatol Rev. 2024;20(5):501-513. doi: 10.2174/0115733971289295240223095751.

Pharmacological strategies for mitigating anti-TNF biologic immunogenicity in rheumatoid arthritis patients.

Curr Opin Pharmacol. 2023 Feb;68:102320. doi: 10.1016/j.coph.2022.102320. Epub 2022 Dec 27.

Assessing Immunogenicity of Biologic Drugs in Inflammatory Joint Diseases: Progress Towards Personalized Medicine.

BioDrugs. 2022 Nov;36(6):731-748. doi: 10.1007/s40259-022-00559-1. Epub 2022 Oct 31.

Therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal disease: a systematic literature review informing EULAR points to consider.

RMD Open. 2022 Jun;8(2). doi: 10.1136/rmdopen-2022-002216.

Serum etanercept concentrations in relation to disease activity and treatment response assessed by ultrasound, biomarkers and clinical disease activity scores: results from a prospective observational study of patients with rheumatoid arthritis.

RMD Open. 2021 Dec;7(3). doi: 10.1136/rmdopen-2021-001985.

Methotrexate Reduces the Probability of Discontinuation of TNF Inhibitors in Seropositive Patients With Rheumatoid Arthritis. A Real-World Data Analysis.

Front Med (Lausanne). 2021 Jun 29;8:692557. doi: 10.3389/fmed.2021.692557. eCollection 2021.

What Is the Clinical Relevance of TNF Inhibitor Immunogenicity in the Management of Patients With Rheumatoid Arthritis?

Front Immunol. 2020 Apr 7;11:589. doi: 10.3389/fimmu.2020.00589. eCollection 2020.

The potential value of blood monitoring of biologic drugs used in the treatment of rheumatoid arthritis.

Ther Adv Musculoskelet Dis. 2020 Feb 7;12:1759720X20904850. doi: 10.1177/1759720X20904850. eCollection 2020.

Introducing Patterns of Variability for Overcoming Compensatory Adaptation of the Immune System to Immunomodulatory Agents: A Novel Method for Improving Clinical Response to Anti-TNF Therapies.

Front Immunol. 2019 Nov 20;10:2726. doi: 10.3389/fimmu.2019.02726. eCollection 2019.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Adalimumab trough concentrations in patients with rheumatoid arthritis and psoriatic arthritis treated with concomitant disease-modifying antirheumatic drugs.

作者信息

Vogelzang E H, Pouw M F, Nurmohamed M, Kneepkens E L, Rispens T, Wolbink G J, Krieckaert C L M

机构信息

Department of Rheumatology, Jan van Breemen Research Institute | Reade, Amsterdam, The Netherlands.

出版信息

Ann Rheum Dis. 2015 Feb;74(2):474-5. doi: 10.1136/annrheumdis-2014-206588. Epub 2014 Nov 28.

DOI:10.1136/annrheumdis-2014-206588

PMID:25433018

Abstract

摘要

Adalimumab trough concentrations in patients with rheumatoid arthritis and psoriatic arthritis treated with concomitant disease-modifying antirheumatic drugs.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Adalimumab trough concentrations in patients with rheumatoid arthritis and psoriatic arthritis treated with concomitant disease-modifying antirheumatic drugs.

作者信息

机构信息

出版信息

相似文献

引用本文的文献